Skip to main content

Peer Review reports

From: Development and internal validation of a model for predicting cefoperazone/sulbactam-associated coagulation disorders in Chinese inpatients

Original Submission
31 Jul 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
10 Aug 2023 Author responded Author comments - Daihong Guo
Resubmission - Version 3
10 Aug 2023 Submitted Manuscript version 3
16 Aug 2023 Author responded Author comments - Daihong Guo
Resubmission - Version 4
16 Aug 2023 Submitted Manuscript version 4
17 Aug 2023 Author responded Author comments - Daihong Guo
Resubmission - Version 5
17 Aug 2023 Submitted Manuscript version 5
20 Oct 2023 Reviewed Reviewer Report
6 Jan 2024 Reviewed Reviewer Report - Vildan Avkan-Oguz
8 Apr 2024 Author responded Author comments - Daihong Guo
Resubmission - Version 6
8 Apr 2024 Submitted Manuscript version 6
5 May 2024 Reviewed Reviewer Report - Vildan Avkan-Oguz
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
24 Jun 2024 Editorially accepted
12 Jul 2024 Article published 10.1186/s40360-024-00761-7

You can find further information about peer review here.

Back to article page